Glaucoma remains a leading cause of irreversible vision impairment, but recent progresses in treatment have offered new possibilities for patients. Novel therapies, such as targeted drug delivery systems and minimally invasive surgical procedures, are gaining traction, aiming to maintain vision by lowering intraocular pressure more effectively. Fur